C Schimanski

637 total citations
15 papers, 390 citations indexed

About

C Schimanski is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, C Schimanski has authored 15 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in C Schimanski's work include Colorectal Cancer Treatments and Studies (4 papers), Genetic factors in colorectal cancer (3 papers) and Gastric Cancer Management and Outcomes (3 papers). C Schimanski is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Genetic factors in colorectal cancer (3 papers) and Gastric Cancer Management and Outcomes (3 papers). C Schimanski collaborates with scholars based in Germany, Switzerland and Italy. C Schimanski's co-authors include Peter R. Galle, Markus Moehler, David Strand, Annalisa Pession, Dennis Strand, Elisa Laurenti, Silke Kuphal, Anja‐Katrin Bosserhoff, P.‐Å. Hofer and F Bataille and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

C Schimanski

15 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Schimanski Germany	9	240	141	138	74	58	15	390
Weimin Hu United States	8	305 1.3×	88 0.6×	188 1.4×	54 0.7×	79 1.4×	10	431
Nina Goerner Spain	3	499 2.1×	139 1.0×	118 0.9×	34 0.5×	73 1.3×	3	595
Anja Hohmeyer Germany	3	234 1.0×	60 0.4×	122 0.9×	91 1.2×	79 1.4×	3	390
Maria Teresa Vento Italy	8	274 1.1×	87 0.6×	153 1.1×	40 0.5×	105 1.8×	9	406
Tri K. Nguyen United States	8	274 1.1×	108 0.8×	99 0.7×	33 0.4×	43 0.7×	10	460
Qianze Dong China	13	320 1.3×	63 0.4×	83 0.6×	56 0.8×	122 2.1×	17	418
Chery A. Whipple United States	8	229 1.0×	102 0.7×	163 1.2×	101 1.4×	100 1.7×	10	396
Zhenzhen Zhou China	11	204 0.8×	39 0.3×	128 0.9×	89 1.2×	64 1.1×	18	373
Costanza Ballarò Italy	7	263 1.1×	44 0.3×	169 1.2×	50 0.7×	77 1.3×	8	399
John Bothos United States	10	334 1.4×	252 1.8×	179 1.3×	43 0.6×	35 0.6×	19	542

Countries citing papers authored by C Schimanski

Since Specialization

Citations

This map shows the geographic impact of C Schimanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Schimanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Schimanski more than expected).

Fields of papers citing papers by C Schimanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Schimanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Schimanski. The network helps show where C Schimanski may publish in the future.

Co-authorship network of co-authors of C Schimanski

This figure shows the co-authorship network connecting the top 25 collaborators of C Schimanski. A scholar is included among the top collaborators of C Schimanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Schimanski. C Schimanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hoehler, Thomas, Thomas Decker, C Schimanski, et al.. (2013). Final results of the AIO 0307 study: A controlled, randomized, double-blind phase II study of FOLFOX6 or FOLFIRI combined with sorafenib (S) versus placebo (P) in second-line metastatic colorectal carcinoma (mCRC) treatment.. Journal of Clinical Oncology. 31(15_suppl). 3586–3586. 3 indexed citations

Biesterfeld, Stefan, et al.. (2012). Preservation of HUGL-1 expression as a favourable prognostic factor in pancreatic carcinoma.. PubMed. 32(8). 3153–9. 10 indexed citations

Moehler, Markus, Florian Lordick, S. Al-Batran, et al.. (2010). An open-label, multicenter phase II trial of SUNITINIB for patients with chemorefractory metastatic gastric cancer. Zeitschrift für Gastroenterologie. 48(8). 1 indexed citations

Herzer, Kerstin, Thomas G. Hofmann, Andreas Teufel, et al.. (2009). IFN-α–Induced Apoptosis in Hepatocellular Carcinoma Involves Promyelocytic Leukemia Protein and TRAIL Independently of p53. Cancer Research. 69(3). 855–862. 66 indexed citations

Drescher, Daniel, Ines Gockel, Markus Moehler, et al.. (2009). Does expression of receptor tyrosine kinases in gastric adenocarcinoma correlate with clinicopathological parameters?. PubMed. 57(98). 131–133. 1 indexed citations

Schulze‐Bergkamen, Henning, Binje Vick, Toni Urbanik, et al.. (2008). Bcl-xL and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells. World Journal of Gastroenterology. 14(24). 3829–3829. 37 indexed citations

Schimanski, C, Thomas Wehler, Peter R. Galle, Ines Gockel, & Markus Moehler. (2008). PDGFR-α/β expression correlates with the metastatic behavior of human colorectal cancer—A rationale for a molecular targeting strategy?. Journal of Clinical Oncology. 26(15_suppl). 22019–22019. 1 indexed citations

Atreya, Imke, C Schimanski, Christoph Becker, et al.. (2007). The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer. Gut. 56(11). 1572–1578. 32 indexed citations

Schimanski, C, et al.. (2006). Immuntherapie des Kolorektalkarzinoms - aktueller Stand und Perspektiven. Zeitschrift für Gastroenterologie. 44(8). 673–681. 1 indexed citations

10.

Kuphal, Silke, Susanne Wallner, C Schimanski, et al.. (2005). Expression of Hugl-1 is strongly reduced in malignant melanoma. Oncogene. 25(1). 103–110. 91 indexed citations

11.

Schimanski, C, et al.. (2004). Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations. International Journal of Colorectal Disease. 19(4). 380–386. 20 indexed citations

12.

Grifoni, Daniela, Flavio Garoia, C Schimanski, et al.. (2004). The human protein Hugl-1 substitutes for Drosophila Lethal giant larvae tumour suppressor function in vivo. Oncogene. 23(53). 8688–8694. 100 indexed citations

13.

Moehler, Markus, Juergen Siebler, C Schimanski, et al.. (2003). Weekly treatment with irinotecan, folinic acid and infusional 5-fluorouracil (ILF) in patients with advanced gastric cancer. Anti-Cancer Drugs. 14(8). 645–650. 16 indexed citations

14.

Schimanski, C, et al.. (2003). Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: Prognostic implications. International Journal of Oncology. 23(3). 791–6. 9 indexed citations

15.

Schimanski, C, et al.. (2001). Extended staging results from the detection of isolated tumor cells in the liver of colorectal cancer patients.. Oncology Reports. 8(1). 185–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact